salicylates and 5-5--methylenedisalicylic-acid

Ser/thr phosphatase Stp1 is an important virulence factor for Staphylococcus aureus (S. aureus) and plays a key role in its infectivity, suggesting that it could serve as a potential target for treatment of S. aureus infection. Previous studies found that the activity of Stp1 was inhibited by MDSA and its derivatives. In this paper, we used molecular docking, molecular modeling, molecular dynamics simulations, binding free energy decomposition calculations, and hydrogen bond analyses to explore the structure-activity relationship. Energy decomposition indicated that MDSA, hydroxymethyl MDSA, carboxymethyl MDSA and methyl MDSA can bind to the catalytic pocket of Stp1. Furthermore, Met39, Ile163, Ile164, Val167, Gly195 and Asp233 were key residues in the Stp1-inhibitor complexes. Due to the lack of a double salicylate structure, salicylic acid cannot bind to the active site of Stpl, leading to loss of inhibitory activity. Based on these results, the structure-activity relationship at the atomic level was determined, which can promote the development of new and more effective anti-drug resistance inhibitors.

Topics: Bacterial Proteins; Computational Biology; Enzyme Inhibitors; Models, Molecular; Molecular Structure; Phosphoprotein Phosphatases; Salicylates; Staphylococcus aureus; Structure-Activity Relationship; Thermodynamics

Chlamydiae are obligate intracellular Gram-negative bacterial pathogens that undergo an essential, but poorly understood, biphasic developmental cycle transitioning between the infectious elementary body and the replicative reticulate body. Ser/Thr/Tyr phosphorylation has been increasingly recognized for its role in regulating bacterial physiology.

Topics: Animals; Bacterial Proteins; Cell Line; Chlamydia trachomatis; Gene Expression Regulation, Bacterial; HeLa Cells; Humans; Mice; Phosphorylation; Protein Phosphatase 2C; Salicylates

SarA (staphylococcal accessory protein A), MgrA (MarR family of global transcriptional regulator A), and SarZ (a paralogue of SarA) play critical roles in modulating the virulence, drug resistance and autolysis of Staphylococcus aureus. Recently, eukaryotic-like Ser/Thr kinase/phosphatases (Stk1/Stp1) were found to modulate phosphorylation of these transcriptional regulators as well as staphylococcal virulence. Importantly, an stp1-deficient strain showed significant virulence reduction in mice, indicative of Stp1 as a potential drug target. Here, we report that MDSA, an inhibitor of MgrA, enhances phosphorylation of SarA/MgrA by inhibiting Stp1 in S. aureus. MDSA is a more-potent inhibitor (IC50 =9.68 ± 0.52 μM) of Stp1 than commonly used phosphatase inhibitors. We anticipate that MDSA could be a lead compound to develop new approaches for reducing staph virulence by targeting Stp1.

Topics: Bacterial Proteins; Dose-Response Relationship, Drug; Phosphoprotein Phosphatases; Phosphorylation; Salicylates; Staphylococcus aureus; Trans-Activators

Increasing antibiotic resistance in human pathogens necessitates the development of new approaches against infections. Targeting virulence regulation at the transcriptional level represents a promising strategy yet to be explored. A global transcriptional regulator, MgrA in Staphylococcus aureus, was identified previously as a key virulence determinant. We have performed a fluorescence anisotropy (FA)-based high-throughput screen that identified 5, 5-methylenedisalicylic acid (MDSA), which blocks the DNA binding of MgrA. MDSA represses the expression of α-toxin that is up-regulated by MgrA and activates the transcription of protein A, a gene down-regulated by MgrA. MDSA alters bacterial antibiotic susceptibilities via an MgrA-dependent pathway. A mouse model of infection indicated that MDSA could attenuate S. aureus virulence. This work is a rare demonstration of utilizing small molecules to block protein-DNA interaction, thus tuning important biological regulation at the transcriptional level.

Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Humans; Mice; Mice, Inbred BALB C; Models, Molecular; Salicylates; Staphylococcal Infections; Staphylococcal Protein A; Staphylococcus aureus; Transcription Factors; Transcriptional Activation; Virulence; Virulence Factors

Methylenedisalicylic acid derivatives were synthesized and their inhibitory activities against protein tyrosine phosphatases (PTPases) examined. Two of the compounds, 8 and 9, showed K(i) values of 9.4 and 6.3microM against PTP1B, 4- and 7-fold lower values compared to those against TC-PTP. They were reversible and slow-binding inhibitors against PTP1B. When compound 8 was fed to a mouse model, the weight gain and adipocyte fat storage induced by a high-fat-diet were significantly suppressed.

Topics: Adipocytes; Animals; Anti-Obesity Agents; Diet; Disease Models, Animal; Mice; Mice, Inbred C57BL; Obesity; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Salicylates; Weight Gain

A cylinder plate assay procedure was studied by 10 laboratories. For premix feeds, 3 samples of bacitracin methylene disalicylic acid and 3 samples of bacitracin zinc premixes covering the range of 10 to 50 g/lb were used. The repeatability standard deviation was 2.11, and the reproducibility standard deviation was 2.13. The average recovery of bacitracin was 101.5%. The method has been adopted official first action. For finished feeds, 6 samples of bacitracin methylene disalicylic acid and 6 samples of bacitracin zinc covering the range of 10 to 800 g/ton were used in the study. The procedure included a sample cleanup step using disposable reverse phase columns. This step appears to be the cause of the poor results reported by most collaborators. Continued study is needed to develop an acceptable method for finished feeds.

Topics: Animal Feed; Bacitracin; Biological Assay; Salicylates; Zinc

A liquid chromatographic technique for the determination of bacitracin in finished feeds and premix feeds consists of an isocratic reverse phase, ion-suppressed technique. The chromatography can be completed in less than 25 min. In a collaborative study involving 9 laboratories and 3 samples of bacitracin methylene disalicylic acid and 3 samples of bacitracin zinc premixes covering the range of 10-50 g/lb, the repeatability standard deviation was 0.55, and the reproducibility standard deviation was 1.35. The average recovery of the bacitracin was 102.0%. The method has been adopted official first action for bacitracin in premix feeds.

Topics: Animal Feed; Bacitracin; Chromatography, High Pressure Liquid; Salicylates; Zinc

Topics: Animals; Binding Sites; Intracellular Membranes; Microsomes; Protein Biosynthesis; Proteins; Rats; Ribosomes; Salicylates; Structure-Activity Relationship

Topics: Aluminum; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Hydroxybenzoates; Naphthalenes; Pharmacy; Potentiometry; Research; Salicylates; Salts